Agmatine and nerve pain
What 2 graded rows on agmatine agree on for nerve pain, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Agmatine page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Agmatine page, with its PubMed record.
Your question
Agmatine and nerve pain
2 rows · 72 peopleThey agree: both rows found an improvement.
- DGrade D× 2
- Rows
- 2
- Trials
- 2
- People
- 72
What the rows share
From the rowsThe best-graded row, grade D, is a randomized trial of 61 people (2010) and found an improvement.
The rows run from 11 to 61 people, published from 2010 to 2020: 2 single studies.
The rows
2 improved- DGrade DPain and quality of life in lumbar disc radiculopathy · Improved
RCT · n 61 · 2010 · Adults with herniated lumbar disc-associated radiculopathy in Israel (99 randomised; 31 agmatine and 30 placebo analysed)
2.67 g/day · 14 days
Average pain improved 26.7% from baseline with agmatine versus 6.0% with placebo, and quality of life 70.8% versus 20.0% (both P ≤ 0.05). No treatment-related adverse events.
- DGrade DNeuropathic pain in painful small fiber neuropathy · Improved
Open-label trial · n 11 · 2020 · Adults with painful small fiber neuropathy (8 diabetic) resistant to standard drugs (USA)
2.67 g/day · 2 months
Neuropathic pain scores fell 46.4% on average (26.0 rating points); every completer improved to some extent.